# pathway_0089

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **B** — Glycan degradation

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MVSFTTLLTAVATAVSAVTASPLEALKRGIQPGTGVHDGYFYSFWTDGRGYVDFNNGPRGSYRVSWSNVNNWVGGKGWNPGPPRRIAYNGTWNNWNVNSYLALYGWTTNPLVEYYIVEAYGSYNPSSGAARLGTIEDDGGVYDIYRTRRINQPSIIGTASFDQYWSVRRQKRVGGTIDTGKHFDEWRRQGNLQLGAWNYMIMATEGYQSSGSAEIEVRSLD

[Multiple Choices]
A. xylan degradation. .
B. Glycan degradation
C. Antifungal biosynthesis. .
D. Pigment biosynthesis. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt entry identifies the protein as endo-1,4-beta-xylanase 11A and annotates both glycan degradation and xylan degradation as pathways. The pathway annotation cites computational RuleBase and PubMed evidence; the cited publication concerns a GH11 xylanase from this fungus and xylan degradation. Thus B is supported, though not uniquely supported over A.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is compatible with a secreted carbohydrate-active enzyme, but that broad inference does not establish its specific substrate or distinguish the pathway labels offered.


**Missing item-specific fact**

> The protein-specific identification and substrate/function evidence showing that this sequence encodes xylanase 11A, along with its pathway annotation, are not supplied in the question.


**Reason**

> Choosing a pathway requires protein-specific functional information absent from the input. The sequence alone does not meaningfully distinguish the two carbohydrate-degradation choices, and recognizing the exact protein from a database would be lookup or memorization rather than reasoning from the supplied information.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> The sequence-matched annotation explicitly lists both xylan degradation and glycan degradation. The question gives no criterion for choosing one as the primary pathway, and xylan degradation is also a specific form of glycan degradation.


### Important caveats

- Reviewer-only database evidence supports the key but was not available to the evaluated model.
- The matched annotation includes computational and cited PubMed evidence; the underlying primary study was not independently reviewed here.
- The historical and current records match the supplied sequence, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is compatible with a secreted carbohydrate-active enzyme, but that broad inference does not establish its specific substrate or distinguish the pathway labels offered.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identification and substrate/function evidence showing that this sequence encodes xylanase 11A, along with its pathway annotation, are not supplied in the question.",
    "reason": "Choosing a pathway requires protein-specific functional information absent from the input. The sequence alone does not meaningfully distinguish the two carbohydrate-degradation choices, and recognizing the exact protein from a database would be lookup or memorization rather than reasoning from the supplied information."
  },
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry identifies the protein as endo-1,4-beta-xylanase 11A and annotates both glycan degradation and xylan degradation as pathways. The pathway annotation cites computational RuleBase and PubMed evidence; the cited publication concerns a GH11 xylanase from this fungus and xylan degradation. Thus B is supported, though not uniquely supported over A."
  },
  "important_caveats": [
    "Reviewer-only database evidence supports the key but was not available to the evaluated model.",
    "The matched annotation includes computational and cited PubMed evidence; the underlying primary study was not independently reviewed here.",
    "The historical and current records match the supplied sequence, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "The sequence-matched annotation explicitly lists both xylan degradation and glycan degradation. The question gives no criterion for choosing one as the primary pathway, and xylan degradation is also a specific form of glycan degradation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry identifies the protein as endo-1,4-beta-xylanase 11A and annotates both glycan degradation and xylan degradation as pathways. The pathway annotation cites computational RuleBase and PubMed evidence; the cited publication concerns a GH11 xylanase from this fungus and xylan degradation. Thus B is supported, though not uniquely supported over A.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is compatible with a secreted carbohydrate-active enzyme, but that broad inference does not establish its specific substrate or distinguish the pathway labels offered.",
    "missing_item_specific_fact": "The protein-specific identification and substrate/function evidence showing that this sequence encodes xylanase 11A, along with its pathway annotation, are not supplied in the question.",
    "reason": "Choosing a pathway requires protein-specific functional information absent from the input. The sequence alone does not meaningfully distinguish the two carbohydrate-degradation choices, and recognizing the exact protein from a database would be lookup or memorization rather than reasoning from the supplied information."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "The sequence-matched annotation explicitly lists both xylan degradation and glycan degradation. The question gives no criterion for choosing one as the primary pathway, and xylan degradation is also a specific form of glycan degradation."
  },
  "important_caveats": [
    "Reviewer-only database evidence supports the key but was not available to the evaluated model.",
    "The matched annotation includes computational and cited PubMed evidence; the underlying primary study was not independently reviewed here.",
    "The historical and current records match the supplied sequence, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt annotation for V9TS54 (Endo-1,4-beta-xylanase 11A from Humicola insolens) explicitly states 'PATHWAY: Glycan degradation; xylan degradation' (evidence C5, H3). The author's key B ('Glycan degradation') is directly listed as the primary pathway heading in the annotation. However, 'xylan degradation' (option A) is also explicitly listed in the same annotation as a sub-pathway, making both A and B textually present in the source.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A model could recognize from the sequence (signal peptide, GH11-family motifs, ~221 aa secreted protein from a fungus) that this is a xylanase. General biological knowledge confirms xylan is a glycan (a polysaccharide), so 'glycan degradation' is a valid broader description. However, distinguishing 'Glycan degradation' (B) from 'xylan degradation' (A) as the 'primary' pathway requires knowledge of UniProt's specific pathway taxonomy convention, where the broader category is listed first as the primary heading and the specific sub-pathway follows after a semicolon.


**Missing item-specific fact**

> The UniProt pathway annotation convention that lists 'Glycan degradation' as the primary pathway heading with 'xylan degradation' as a subordinate sub-pathway. Without this database-specific taxonomy convention, a model identifying the protein as a xylanase would more naturally select 'xylan degradation' (A) as the most specific and relevant pathway.


**Reason**

> Biological reasoning identifies the protein as a xylanase degrading xylan (a glycan). Both 'xylan degradation' and 'glycan degradation' are valid biological descriptions. The choice of B over A depends on knowing UniProt's hierarchical pathway naming convention (broader category first as 'primary'), which is an annotation-specific fact rather than a general biological inference.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> The UniProt annotation explicitly lists both 'Glycan degradation' AND 'xylan degradation' in the same PATHWAY comment (C5: 'Glycan degradation; xylan degradation'). Option A ('xylan degradation') is the more specific and arguably more informative pathway for a xylanase, while option B ('Glycan degradation') is the broader category. The question asks for the 'primary' pathway, but the annotation does not clearly designate one as primary over the other beyond ordering convention. A model reasoning from the protein's specific function (xylan hydrolysis) would defensibly select A.


### Important caveats

- Both A and B are explicitly present in the UniProt pathway annotation; the distinction is a taxonomy hierarchy convention, not a factual disagreement.
- The pathway annotation evidence code includes ECO:0000255 (RuleBase, computational inference) and ECO:0000269 (PubMed, experimental), so the annotation has experimental support for the enzyme's function.
- The protein is a GH11 endo-1,4-beta-xylanase (EC 3.2.1.8) with experimental characterization (PubMed 24262572), confirming xylanase activity.
- The author's accession identification was inferred from dataset metadata (reviewer-only), though the sequence match is confirmed.
- Options C (Antifungal biosynthesis) and D (Pigment biosynthesis) are clearly incorrect distractors with no relation to a secreted glycoside hydrolase.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A model could recognize from the sequence (signal peptide, GH11-family motifs, ~221 aa secreted protein from a fungus) that this is a xylanase. General biological knowledge confirms xylan is a glycan (a polysaccharide), so 'glycan degradation' is a valid broader description. However, distinguishing 'Glycan degradation' (B) from 'xylan degradation' (A) as the 'primary' pathway requires knowledge of UniProt's specific pathway taxonomy convention, where the broader category is listed first as the primary heading and the specific sub-pathway follows after a semicolon.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The UniProt pathway annotation convention that lists 'Glycan degradation' as the primary pathway heading with 'xylan degradation' as a subordinate sub-pathway. Without this database-specific taxonomy convention, a model identifying the protein as a xylanase would more naturally select 'xylan degradation' (A) as the most specific and relevant pathway.",
    "reason": "Biological reasoning identifies the protein as a xylanase degrading xylan (a glycan). Both 'xylan degradation' and 'glycan degradation' are valid biological descriptions. The choice of B over A depends on knowing UniProt's hierarchical pathway naming convention (broader category first as 'primary'), which is an annotation-specific fact rather than a general biological inference."
  },
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4"
    ],
    "judgment": "supported",
    "reason": "The UniProt annotation for V9TS54 (Endo-1,4-beta-xylanase 11A from Humicola insolens) explicitly states 'PATHWAY: Glycan degradation; xylan degradation' (evidence C5, H3). The author's key B ('Glycan degradation') is directly listed as the primary pathway heading in the annotation. However, 'xylan degradation' (option A) is also explicitly listed in the same annotation as a sub-pathway, making both A and B textually present in the source."
  },
  "important_caveats": [
    "Both A and B are explicitly present in the UniProt pathway annotation; the distinction is a taxonomy hierarchy convention, not a factual disagreement.",
    "The pathway annotation evidence code includes ECO:0000255 (RuleBase, computational inference) and ECO:0000269 (PubMed, experimental), so the annotation has experimental support for the enzyme's function.",
    "The protein is a GH11 endo-1,4-beta-xylanase (EC 3.2.1.8) with experimental characterization (PubMed 24262572), confirming xylanase activity.",
    "The author's accession identification was inferred from dataset metadata (reviewer-only), though the sequence match is confirmed.",
    "Options C (Antifungal biosynthesis) and D (Pigment biosynthesis) are clearly incorrect distractors with no relation to a secreted glycoside hydrolase."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "The UniProt annotation explicitly lists both 'Glycan degradation' AND 'xylan degradation' in the same PATHWAY comment (C5: 'Glycan degradation; xylan degradation'). Option A ('xylan degradation') is the more specific and arguably more informative pathway for a xylanase, while option B ('Glycan degradation') is the broader category. The question asks for the 'primary' pathway, but the annotation does not clearly designate one as primary over the other beyond ordering convention. A model reasoning from the protein's specific function (xylan hydrolysis) would defensibly select A."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt annotation for V9TS54 (Endo-1,4-beta-xylanase 11A from Humicola insolens) explicitly states 'PATHWAY: Glycan degradation; xylan degradation' (evidence C5, H3). The author's key B ('Glycan degradation') is directly listed as the primary pathway heading in the annotation. However, 'xylan degradation' (option A) is also explicitly listed in the same annotation as a sub-pathway, making both A and B textually present in the source.",
    "evidence_ids": ["C5", "H3", "C4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A model could recognize from the sequence (signal peptide, GH11-family motifs, ~221 aa secreted protein from a fungus) that this is a xylanase. General biological knowledge confirms xylan is a glycan (a polysaccharide), so 'glycan degradation' is a valid broader description. However, distinguishing 'Glycan degradation' (B) from 'xylan degradation' (A) as the 'primary' pathway requires knowledge of UniProt's specific pathway taxonomy convention, where the broader category is listed first as the primary heading and the specific sub-pathway follows after a semicolon.",
    "missing_item_specific_fact": "The UniProt pathway annotation convention that lists 'Glycan degradation' as the primary pathway heading with 'xylan degradation' as a subordinate sub-pathway. Without this database-specific taxonomy convention, a model identifying the protein as a xylanase would more naturally select 'xylan degradation' (A) as the most specific and relevant pathway.",
    "reason": "Biological reasoning identifies the protein as a xylanase degrading xylan (a glycan). Both 'xylan degradation' and 'glycan degradation' are valid biological descriptions. The choice of B over A depends on knowing UniProt's hierarchical pathway naming convention (broader category first as 'primary'), which is an annotation-specific fact rather than a general biological inference."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "The UniProt annotation explicitly lists both 'Glycan degradation' AND 'xylan degradation' in the same PATHWAY comment (C5: 'Glycan degradation; xylan degradation'). Option A ('xylan degradation') is the more specific and arguably more informative pathway for a xylanase, while option B ('Glycan degradation') is the broader category. The question asks for the 'primary' pathway, but the annotation does not clearly designate one as primary over the other beyond ordering convention. A model reasoning from the protein's specific function (xylan hydrolysis) would defensibly select A."
  },
  "important_caveats": [
    "Both A and B are explicitly present in the UniProt pathway annotation; the distinction is a taxonomy hierarchy convention, not a factual disagreement.",
    "The pathway annotation evidence code includes ECO:0000255 (RuleBase, computational inference) and ECO:0000269 (PubMed, experimental), so the annotation has experimental support for the enzyme's function.",
    "The protein is a GH11 endo-1,4-beta-xylanase (EC 3.2.1.8) with experimental characterization (PubMed 24262572), confirming xylanase activity.",
    "The author's accession identification was inferred from dataset metadata (reviewer-only), though the sequence match is confirmed.",
    "Options C (Antifungal biosynthesis) and D (Pigment biosynthesis) are clearly incorrect distractors with no relation to a secreted glycoside hydrolase."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `V9TS54` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 39. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/V9TS54.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:30.137210+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"1,4-beta-D-xylan xylanohydrolase 11A"}}],"flag":"Precursor","recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"24262572","source":"PubMed"}],"value":"3.2.1.8"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"24262572","source":"PubMed"}],"value":"Endo-1,4-beta-xylanase 11A"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"24262572","source":"PubMed"}],"value":"Xylanase 11A"}]}}
```

Source SHA-256: `53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/V9TS54.json)  
**Locator:** `/comments/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:30.137210+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000255","id":"RU362015","source":"RuleBase"},{"evidenceCode":"ECO:0000269","id":"24262572","source":"PubMed"}],"value":"Glycan degradation; xylan degradation"}]}
```

Source SHA-256: `53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/V9TS54.json)  
**Locator:** `/references/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:30.137210+00:00.  

```json
{"citation":{"authors":["Yang X.","Shi P.","Huang H.","Luo H.","Wang Y.","Zhang W.","Yao B."],"citationCrossReferences":[{"database":"PubMed","id":"24262572"},{"database":"DOI","id":"10.1016/j.foodchem.2013.10.062"}],"citationType":"journal article","firstPage":"381","id":"24262572","journal":"Food Chem.","lastPage":"387","publicationDate":"2014","title":"Two xylose-tolerant GH43 bifunctional ?-xylosidase/?-arabinosidases and one GH11 xylanase from Humicola insolens and their synergy in the degradation of xylan.","volume":"148"},"referenceComments":[{"type":"STRAIN","value":"Y1"}],"referenceNumber":1,"referencePositions":["NUCLEOTIDE SEQUENCE [MRNA]","FUNCTION","CATALYTIC ACTIVITY","BIOPHYSICOCHEMICAL PROPERTIES","SUBSTRATE SPECIFICITY","ACTIVITY REGULATION","BIOTECHNOLOGY"]}
```

Source SHA-256: `53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/V9TS54?format=txt&versions=39)  
**Locator:** `lines 48-49`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 39 / 1.  
**Retrieved:** 2026-11-01T06:28:53.416982+00:00.  

```text
CC   -!- PATHWAY: Glycan degradation; xylan degradation.
CC       {ECO:0000255|RuleBase:RU362015, ECO:0000269|PubMed:24262572}.
```

Source SHA-256: `a074e123d2ec0589aa06f4931d85860d82aaf183072ecb88102fc2c6e967dd34`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 89. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
